A prospective, randomized, comparative trial of a COX-2 selective nonsteroidal anti-inflammatory drug versus placebo in inguinal herniorrhaphy patients

被引：0
|
作者：
M. J. Schurr
L. D. Faucher
机构：
[1] University of Wisconsin Hospital,Department of Surgery
来源：
Hernia | 2009年 / 13卷
关键词：
Pain; Opioids; Activities of daily living; Hernia repair; COX-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：491 / 497
页数：6
相关论文
共 50 条
  • [1] A prospective, randomized, comparative trial of a COX-2 selective nonsteroidal anti-inflammatory drug versus placebo in inguinal herniorrhaphy patients
    Schurr, M. J.
    Faucher, L. D.
    HERNIA, 2009, 13 (05) : 491 - 497
  • [2] Nonsteroidal anti-inflammatory drugs versus selective COX-2 inhibitors in the upper gastrointestinal tract
    Schoelmerich, Juergen
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 : S67 - S71
  • [3] Role of COX-2 in nonsteroidal anti-inflammatory drug enteropathy in rodents
    Hotz-Behofsits, Christoph
    Simpson, Robert J.
    Walley, Matthew
    Bjarnason, Ingvar T.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (7-8) : 822 - 827
  • [4] The Effect of Nonsteroidal Anti-inflammatory Drugs and Selective COX-2 Inhibitors on Bone Healing
    White, Alexander E.
    Henry, Jensen K.
    Dziadosz, Daniel
    HSS JOURNAL, 2021, 17 (02) : 231 - 234
  • [5] COX-2 Selective Nonsteroidal Anti-Inflammatory DrugsDo They Really Offer Any Advantages?
    Lucina M. Jackson
    Christopher J. Hawkey
    Drugs, 2000, 59 : 1207 - 1216
  • [6] Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs
    Dona, I.
    Blanca-Lopez, N.
    Jagemann, L. R.
    Torres, M. J.
    Rondon, C.
    Campo, P.
    Gomez, A. I.
    Fernandez, J.
    Laguna, J. J.
    Rosado, A.
    Blanca, M.
    Canto, G.
    ALLERGY, 2011, 66 (11) : 1428 - 1433
  • [7] Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer
    Patrignani, P
    TOXICOLOGY LETTERS, 2000, 112 : 493 - 498
  • [8] Gastric and cardiovascular effects of COX-1 and COX-2 selective nonsteroidal anti-inflammatory drugs
    Adami, M.
    Coppelli, G.
    Guaita, E.
    Giovannini, E.
    Coruzzi, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 58 - 58
  • [9] Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug - A review
    Del Tacca, M
    Colucci, R
    Fornai, M
    Blandizzi, C
    CLINICAL DRUG INVESTIGATION, 2002, 22 (12) : 799 - 818
  • [10] Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients:: Comparison of nimesulide, meloxicam, and rofecoxib
    Bavbek, S
    Çelik, G
    Özer, F
    Mungan, D
    Misirligil, Z
    JOURNAL OF ASTHMA, 2004, 41 (01) : 67 - 75
12345